Clopidogrel vs. Aspirin in Patients at Risk of Ischemic Events "CAPRIE"

Completed

Phase 3 Results

Summary of Purpose

To test the relative efficacy of clopidogrel (75 mg once daily ) and aspirin (325 mg once daily) for prevention of stroke, myocardial infarction or vascular death.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 July 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, double-blind, international trial of 19,185 patients at 384 centers in 16 countries.

Contacts

Not available